PC

Prakash Chandra

Active Director Director DIN 08286173
DIN 08286173 First appointment Nov 2018 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Prakash Chandra

Data last updated:

Prakash Chandra is a Director at Shinemed Pharmaceuticals Private Limited (since 2018). The company operates in Food And Beverages. Shinemed Pharmaceuticals Private Limited reported revenue of ₹17.9 Lakh (FY 2024).

DIN 08286173
Primary Designation Director
Industry Food And Beverages
First Appointment 26 Nov 2018
Oldest Company Age 8 yrs
Largest company Shinemed Pharmaceuticals Private Limited · ₹17.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Nov 20182018₹17.9 Lakh (FY 2024)Active

Board colleagues of Prakash Chandra

Directorship timeline

Open interactive timeline →
Shinemed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prakash Chandra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Chandra

Prakash Chandra currently holds 1 directorship: Shinemed Pharmaceuticals Private Limited (Director, since 26 Nov 2018, revenue ₹17.9 Lakh (FY 2024)).

Prakash Chandra was first appointed on 26 Nov 2018 as Director at Shinemed Pharmaceuticals Private Limited.

The current boards of Prakash Chandra's companies include Kumari Keshari Vartika (Shinemed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available